Assignee
ARBOR PHARMACEUTICALS LLC
US·16 granted patents·23 pending applications·32 citations·filing 2013–2025
Top patents by PatentIndex Score
39 records- 0195US11517563B2Liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2022·Granted Dec 6, 2022·5 cites·5 claims
- 0295US11413277B2Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2021·Granted Aug 16, 2022·5 cites·8 claims
- 0391US11938111B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Granted Mar 26, 2024·1 cites·7 claims
- 0490US11013703B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2019·Granted May 25, 2021·2 cites·19 claims
- 0590US10576055B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Mar 3, 2020·2 cites·16 claims
- 0690US10342787B1Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Jul 9, 2019·7 cites·20 claims
- 0789US11229621B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Jan 25, 2022·2 cites·7 claims
- 0889US10576070B2Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2019·Granted Mar 3, 2020·5 cites·24 claims
- 0988US12440468B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2024·Granted Oct 14, 2025·0 cites·12 claims
- 1088US12290495B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2023·Granted May 6, 2025·0 cites·15 claims
- 1187US11850222B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Dec 26, 2023·1 cites·17 claims
- 1282US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 1380US2024240229A1Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1480US2025319048A1Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 1579US2022095621A1Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1679US2022159961A1Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1779US2024024249A1Oral dosage forms having a high loading of a methyl hydrogen fumarate prodrugARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1878US10945984B2Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2013·Granted Mar 16, 2021·1 cites·12 claims
- 1978US2025114457A1Pharmaceutical compositions of fumaric acid estersARBOR PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 2077US2020087272A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2176US2021179573A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2276US2022251031A1Crystalline Form of y-Aminobutyric Acid AnalogARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2376US2018242584A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2474US2020147019A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2573US2019166844A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2672US11229207B2Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head liceARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Jan 25, 2022·0 cites·10 claims
- 2771US2024197661A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2870US11135296B2Pharmaceutical compositions of fumaric acid estersARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Oct 5, 2021·0 cites·7 claims
- 2970US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3070US2020323804A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3170US2020283376A1Crystalline Form of y-Aminobutyric Acid AnalogARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3269US2019256481A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3369US2019256480A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3467US2019152900A1CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOGARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3567US2017118985A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3667US2022241420A1Pharmaceutical Compositions of Fumaric Acid EstersARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3766US10385014B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Aug 20, 2019·0 cites·11 claims
- 3864US2019247345A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 3961US2021228525A1Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side EffectsARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARBOR PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →